Prevention of Hepatitis B Recurrence in Liver Transplant Patients Using Oral Antiviral Therapy without Long-Term Hepatitis B Immunoglobulin

BACKGROUND: Small studies have suggested that nucleos(t)ide analogue therapy (NAT) with reduced hepatitis B immunoglobulin (HBIG) duration may be efficacious in preventing post-liver transplantation (LT) HBV recurrence. OBJECTIVES: This larger study evaluates the use of NAT with short term (< 6 m...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ahn, Joseph, Cohen, Stanley Martin
Format: Artigo
Jezik:Inglês
Izdano: Kowsar 2011
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227486/
https://ncbi.nlm.nih.gov/pubmed/22140388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/kowsar.1735143X.717
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki